J&J ordered to pay $846 million for role in opioid crisis


The pharmaceutical company says it will appeal the judgement A judge has fined drug manufacturer Johnson & Johnson and its pharmaceutical subsidiary Janssen US$572 million (AUD$846 million) after finding the company breached the state’s public nuisance law in promoting opioid products while downplaying their risks and overstating their efficacy. Judge Thad Balkman of the Cleveland

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Negotiating leases and shopping centre rents
Next Docs cutting noses off to spite their face: Tassone